Interestingly, the baseline AST/ALT ratio of individuals developing cancers (median: 1.23, IQR: 0.96–1.54) was significantly greater than that of patients diagnosed with cancer (median: 1.11, IQR: 0.91–1.44) and individuals without cancer (median: 1.15, IQR: 0.91–1.44). The gene discussed is GPT; the disease is cancer.